Celestial Biolabs launches ‘Cadalmin GAe’

19 Sep 2013 Evaluate

Celestial Biolabs has launched a new product ‘Cadalmin GAe' which is a break through research in the management of joint paints of any aetiology. Cadalmin GAe provides relief to people suffering from Arthritis, Lumbago, Gout, Rheumatoid, Low back ache, Sciatica etc. This product is developed at CMFRI (Central Marine Fisheries Research Institute) a prestigious institute of Indian Council of Agricultural Research. This new product is a result of Experimental & clinical study exhibited Cadalmin GAe to be Mother Nature's first ever effective, well tolerated, safe research molecule devoid of harmful side effects.

Celestial Biolabs (CBL) has been supporting Pharma, Bio-pharma and Biotech manufacturing with customized ITsolutions and contract research. CBL also involved in the R&D, commercial production and marketing of enzymes, nutraceuticals. Celestial Biolabs is setting up a biotechnology facility in Genome Valley at Hyderabad, India to manufacture its own drug molecules, industrial enzymes and to contract research activities.

Celestial Biolabs Share Price

2.43 0.00 (0.00%)
11-Mar-2020 18:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1493.35
Dr. Reddys Lab 5879.05
Cipla 1358.80
Zydus Lifesciences 967.80
Lupin 1585.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.